Blood Urea Nitrogen (BUN)

I am a returning customer
I want this for my family

Product Description

The liver produces urea in the urea cycle i.e., when proteins get digested. The ammonia produced during the urea cycle combines with carbon, hydrogen or oxygen to form urea. The urea is removed by the kidney and is filtered from the blood.
The urea is then excreted through the urine. If the concentration of the Urea is abnormal in the blood, it is highly indicative of a kidney disorder. Blood Urea Nitrogen is a very common test that gives you an indication of how well your kidneys and liver are working. A BUN test measures the amount of urea nitrogen in your blood. It is also used to help determine the effectiveness of dialysis treatment if you’re receiving haemodialysis. The test is always a part of the routine health check-up and diagnoses number of other conditions, such as liver damage, urinary tract obstruction, congestive heart failure or gastrointestinal bleeding — although an abnormal BUN test result alone doesn’t confirm any of these conditions.
BUN is often ordered with creatinine when kidney problems are suspected. Some signs and symptoms of kidney dysfunction include Fatigue, poor appetite, or trouble sleeping, swelling or puffiness (edema), particularly around the eyes or in the face, wrists, abdomen, thighs, or ankles. urine that is foamy, bloody, or coffee-colored, a decrease in the amount of urine, problems urinating, such as a burning feeling or abnormal discharge during urination, or a change in the frequency of urination, especially at night.

FeatureValue
SpecimenSerum (Blood)
Related TestsAlbumin; Liver Panel; Protein Electrophoresis; Creatinine; Urine Protein
Schedule Visit
Opt for Metropolis, The Pathology Specialist
The Metropolis Edge

The Metropolis Edge

  • Report trusted by Doctors.
  • Global & National Quality Accreditations – CAP (USA) and NABL , Govt. of India.
  • Guaranteed error free diagnosis.
  • Bar Coded and automated process. No room for manual errors.
  • Specific normal range for Indian population built from 33 years of experience.
  • Sample collection from home/office.
Metropolis: Experience + Expertise

Metropolis: Experience + Expertise

Over the past 3 decades we have earned the respect of doctors and patients. Today we conduct over 30 million tests annually with accuracy each year. Our repertoire extends over 4500 tests and over 100 different technologies. Our customer care is available round the clock for any queries that you may have.

Reach out to our Counsellors
Comprehensive Analysis Of Your Health
Save tax on the Preventive health check-ups up to Rs. 5000, under section 80D of Income Tax Act, 1961
We are Metropolis - Your Pathology Specialist

Metropolis is one of the leading diagnostics companies in India, by revenue, as of March 31, 2018 (Source: Frost & Sullivan). With operations across India, Africa, South Asia and Middle East.

Our globally accredited clinical laboratories deliver millions of accurate and timely test results every year. We offer a comprehensive range of clinical laboratory tests and profiles which are used in prediction, early detection, diagnostic screening, confirmation and monitoring of diseases.

 

  • Delivering diagnostic services since 1980
  • Network of 100+ clinical labs & 1100+ patient touch points
  • Qualified team of phlebotomists for Home collection services

 

  • Certified NABL and CAP accredited labs
  • Wide range of 4000+ tests & profiles
  • Convenience of home collection service

 

Metropolis Healthcare Limited is proposing subject to applicable statutory or regulatory requirements, receipt of requisite approvals, market conditions and other considerations to undertake an initial public offering of its equity shares and has filed a draft red herring prospectus dated September 27, 2018 (“DRHP”) with the Securities and Exchange Board of India (“SEBI”). The DRHP is available on the website of the SEBI at www.sebi.gov.in, BSE Limited at www.bseindia.com, National Stock Exchange of India Limited at www.nseindia.com and the websites of Book Running Lead Managers at www.jmfl.com, www.credit-suisse.com, www.investmentbank.kotak.com, www.hdfcbank.com and www.goldmansachs.com. Any potential investors should note that investment in equity shares involves a high degree of risk and for details relating to same, please refer to the DRHP including the section “Risk Factors” of the DRHP. Potential investors should not rely on the DRHP filed with the SEBI for making any investment decision.

 

Scroll Up